scispace - formally typeset
O

Oskar Ortiz

Researcher at Spanish National Research Council

Publications -  22
Citations -  1646

Oskar Ortiz is an academic researcher from Spanish National Research Council. The author has contributed to research in topics: Transcription activator-like effector nuclease & Gene targeting. The author has an hindex of 15, co-authored 22 publications receiving 1382 citations. Previous affiliations of Oskar Ortiz include Technische Universität München & Merck KGaA.

Papers
More filters
Journal ArticleDOI

Development of an intein-mediated split–Cas9 system for gene therapy

TL;DR: It is revealed for the first time that intein-mediated split–Cas9 can be packaged, delivered and its nuclease activity reconstituted efficiently, in cells via rAAV.
Journal ArticleDOI

Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids.

TL;DR: It is reported that CB1 and adenosine A2A receptors form heteromeric complexes in co-transfected HEK-293T cells and rat striatum, where they colocalize in fibrilar structures and counteracted the motor depressant effects produced by the intrastriatal administration of a cannabinoid CB1 receptor agonist.
Journal ArticleDOI

D1 but not D5 Dopamine Receptors Are Critical for LTP, Spatial Learning, and LTP-Induced arc and zif268 Expression in the Hippocampus

TL;DR: The results indicate that D(1)R but not D(5)R are critical for hippocampal LTP and for the induction of Zif268 and Arc, proteins required for the transition from E-LTP to L-L TP and for memory consolidation in mammals.
Journal ArticleDOI

Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides

TL;DR: This work presents an advanced approach for the production of mouse disease models by microinjection of transcription activator-like effector nucleases (TALENs) and synthetic oligodeoxynucleotides into one-cell embryos, and enables instant germline modifications, making heterozygous mutants available within 18 wk.